31 – 40 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
TAP1-Deficiency Does Not Alter Atherosclerosis Development in Apoe(-/-) Mice.
(
- Contribution to journal › Article
-
Mark
Low Levels of Circulating CD4+FoxP3+ T Cells Are Associated With an Increased Risk for Development of Myocardial Infarction But Not for Stroke.
(
- Contribution to journal › Article
-
Mark
Elevated CD14++CD16- Monocytes Predict Cardiovascular Events.
(
- Contribution to journal › Article
-
Mark
Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
(
- Contribution to journal › Article
-
Mark
Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation.
(
- Contribution to journal › Article
- 2011
-
Mark
Immunization with cationized BSA inhibits progression of disease in ApoBec-1/LDL receptor deficient mice with manifest atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
(
- Contribution to journal › Article
- 2010
-
Mark
Fc{gamma}RIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
(
- Contribution to journal › Article
-
Mark
Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe(-/-) mice.
(
- Contribution to journal › Article